Explore the latest insights on the SA HIV Treatment Programme, revealing critical changes in treatment enrollment and funding.
You must be a subscriber to access all of this content.
Discover the implications of SA's missing middle, where rising medical scheme costs leave many without adequate healthcare options.
You must be a subscriber to access all of this content.
GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends.
You must be a subscriber to access all of this content.
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa's local manufacturing goals.
You must be a subscriber to access all of this content.
South Africa's Lenacapavir rollout begins on June 5, 2026, offering a new HIV prevention tool in high-burden districts.
You must be a subscriber to access all of this content.
Discover the benefits of the Africa Vaccine Procurement Framework for vaccine manufacturing and demand aggregation in Africa.
You must be a subscriber to access all of this content.